RSV
Respiratory Syncytial Virus
The CANVAS surveillance network aims to find out how often health problems occur after an RSV vaccine. This could provide information on frequency and severity of adverse events from RSV vaccines.
Location: British Columbia.
Study Summary
The Canadian National Vaccine Safety (CANVAS) network’s RSV Study is conducting active safety surveillance for RSV vaccines.
The primary objective of the RSV Study is to monitor the safety of RSV vaccines by tracking and comparing health events in vaccinated and unvaccinated groups. A secondary objective is to look at whether health events occur differently when the RSV vaccine is given in combination with COVID-19 and/or influenza vaccine(s).
Study participants will receive an email 8 days after they have received their RSV vaccination inviting them to respond to an online survey. If a participant has also received a COVID-19 and/or influenza vaccine at the same time as their RSV vaccine they will receive one combined survey for all vaccines received (RSV plus COVID-19 and/or influenza).
The CANVAS RSV study is currently active in British Columbia. After collecting and analyzing the data, we will post the study results on this site. Please check back later.
